Illustrative

FDA Approves Eli Lilly's Obesity Pill, Foundayo

Time Magazine·Apr 2

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The FDA has approved a new obesity pill, Foundayo, developed by Eli Lilly. The pill is a GLP-1 weight loss medication, and its approval may impact the market for weight loss drugs. The approval of Foundayo may also lead to competition with other companies, such as Novo Nordisk.

Full coverage

FDA approves Eli Lilly’s weight-loss pill; Judge revokes citizenship over stolen medical secrets for China; new COVID-19 ‘Cicada’ variant spreads to 25 states – Morning Medical Update

Medical Economics·1d ago

FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market

CNBC·Apr 1

Explainer: What to Know About Foundayo, Eli Lilly’s New Once-Daily Weight-Loss Pill

U.S. News & World Report·Apr 2

View original report at Time Magazine ↗

Fetching the latest headlines…

FDA Approves Eli Lilly's Obesity Pill, Foundayo

Full coverage

FDA approves Eli Lilly’s weight-loss pill; Judge revokes citizenship over stolen medical secrets for China; new COVID-19 ‘Cicada’ variant spreads to 25 states – Morning Medical Update

FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market

The FDA approves a new obesity pill, giving patients another option

FDA approves Lilly obesity pill, triggering battle with Novo Nordisk

FDA approves GLP-1 weight loss pill Foundayo from Eli Lilly

F.D.A. Approves New Eli Lilly Weight-Loss Pill, Foundayo - The New York Times

FDA grants speedy approval to Eli Lilly weight-loss pill

Explainer: What to Know About Foundayo, Eli Lilly’s New Once-Daily Weight-Loss Pill